Semintra Telmisartan Oral Solution

Semintra is Boehringer Ingelheim’s telmisartan oral solution for cats. This product identifies the 4 mg/mL, 30 mL presentation, whose European reference concerns reduction of proteinuria associated with chronic kidney disease.

Product features at a glance

• Telmisartan oral solution for cats.
• 4 mg/mL × 30 mL presentation with measuring syringe.
• Separate from the 10 mg/mL market formulation.

How telmisartan is classified

Telmisartan is an angiotensin-II receptor blocker. This class acts on a signalling pathway involved in vascular and renal function. The prescribed role depends on the named formulation and clinical assessment, rather than the Semintra brand alone.

Why concentration must stay with the brand

The pictured box identifies 4 mg/mL in a 30 mL bottle with a measuring syringe. The 10 mg/mL product is a separate concentration with its own label. Do not transfer instructions by matching only the telmisartan ingredient or bottle color.

Monitoring the cat’s response

The veterinarian establishes the relevant kidney or blood-pressure plan and follow-up. Keep other medicines and clinical changes recorded for that review. A liquid concentration is a packaging specification, not an amount to give to a particular cat.

A clear liquid-medicine enquiry

Include the concentration, bottle volume and prescription details. Use the measuring device and handling instructions for the exact product. The 30 mL quantity describes the bottle and should not be read as a fixed treatment duration.